REALMENT is a 4 year-project funded by the European Commission that aims to optimise the treatment of mental disorders through novel precision medicine strategies based on current pharmaceutical options. The project’s efforts will bring world-leading research institutes and the pharmaceutical industry at the forefront of mental disorder research.

REALMENT will achieve its objectives by exploiting population-scale Real-World Data (RWD) in combination with Randomized Clinical Trial (RCT) data available to the partners. Big data from populations (Nordic registries), cohorts (European biobanks), and eHealth samples (medical records), including whole genome genotypes (n=1.9 million), will be analysed in an EU-wide sustainable infrastructure using artificial intelligence and machine learning to develop prediction and stratification tools (precision psychiatry).

Learn more about the project here.